SB
ALNY icon

Suntrust Banks’s Alnylam Pharmaceuticals ALNY Stock Holding History

Suntrust Banks’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,198
Closed -$1.08M – 1230
2017
Q3 		$1.08M Buy
9,198
+5,178
+129% +$442K 0.01% 713
2017
Q2 		$321K Buy
+4,020
New +$257K ﹤0.01% 1019
2014
Q4 		– Sell
-3,714
Closed -$290K – 1171
2014
Q3 		$290K Sell
3,714
-146
-4% -$9.42K ﹤0.01% 1179
2014
Q2 		$243K Sell
3,860
-1,624
-30% -$96.5K ﹤0.01% 1292
2014
Q1 		$367K Buy
5,484
+1
+0% +$77 ﹤0.01% 1483
2013
Q4 		$352K Buy
5,483
+2
+0% +$119 ﹤0.01% 1441
2013
Q3 		$350K Buy
+5,481
New +$273K ﹤0.01% 1406

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM